|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/403 | (2006.01) |
| C07D 209/52 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 3597189 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19196556.5 |
| Date of filing the European patent application | 2016-06-17 | |
| (97) | Date of publication of the European application | 2020-01-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-01 |
| (46) | Date of publication of the claims translation | 2022-07-11 |
| (30) | Number | Date | Country code |
| 201562181174 P | 2015-06-17 | US |
| (72) |
MCKINNEY, Anthony Alexander , US
BYMASTER, Franklin , US
PISKORSKI, Walter , US
FLEITZ, Fred J. , US
YANG, Yonglai , US
ENGERS, David A. , US
SMOLENSKAYA, Valeriya , US
KUSUKUNTLA, Venkat , US
|
| (73) |
Otsuka America Pharmaceutical, Inc. ,
2440 Research Boulevard, Rockville, MD 20850,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kristaliniai junginiai |
| CRYSTALLINE COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-05-19 | 10 | 231.00 EUR |
| 2026-06-17 |